Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 14, Issue 9 2018
http://www.tandfonline.com/toc/khvi20/current

article commentary
Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
Scott B. Halstead
Pages: 2158-2162
Published online: 14 May 2018